120 related articles for article (PubMed ID: 35441872)
1. Perioperative cell-free DNA trends predict recurrence of non-metastatic colorectal cancer significantly earlier than CEA trends over the first 2 years post-operatively in stage II and stage III colon cancer.
Fleming CA; Jordan P; O'Leary DP; Corrigan MA; Wang JH; Redmond HP
Int J Colorectal Dis; 2022 May; 37(5):1119-1126. PubMed ID: 35441872
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancer.
Hassan F; Wang JH; Cullinane C; Ita M; Corrigan M; O'Leary DP; Redmond HP
Surg Oncol; 2022 Jun; 42():101753. PubMed ID: 35594723
[TBL] [Abstract][Full Text] [Related]
3. Persistent high levels of carcinoembryonic antigen after tumor resection are associated with poorer survival outcomes in patients with resected colon cancer.
Muñoz-Montaño WR; López-Basave HN; Castillo-Morales A; Castillo-Morales C; Sánchez-Trejo K; Catalán R; Díaz-Romero C; Lino-Silva LS; Maliachi-Díaz A; Ruiz-García E; Herrera-Martínez M; Calderillo-Ruíz G
BMC Cancer; 2023 Jul; 23(1):678. PubMed ID: 37468881
[TBL] [Abstract][Full Text] [Related]
4. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
Shinkins B; Primrose JN; Pugh SA; Nicholson BD; Perera R; James T; Mant D
Br J Surg; 2018 May; 105(6):658-662. PubMed ID: 29579327
[TBL] [Abstract][Full Text] [Related]
5. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
[TBL] [Abstract][Full Text] [Related]
6. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
[TBL] [Abstract][Full Text] [Related]
7. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer.
Bhatti I; Patel M; Dennison AR; Thomas MW; Garcea G
Int J Surg; 2015 Apr; 16(Pt A):123-128. PubMed ID: 25771102
[TBL] [Abstract][Full Text] [Related]
8. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
Lechner P; Lind P; Goldenberg DM
J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.
Fakih M; Sandhu J; Wang C; Kim J; Chen YJ; Lai L; Melstrom K; Kaiser A
JAMA Netw Open; 2022 Mar; 5(3):e221093. PubMed ID: 35258578
[TBL] [Abstract][Full Text] [Related]
11. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
13. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
Wanebo JH; Stearns M; Schwartz MK
Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of perioperative change of CEA level in colorectal patients when pre-operative level is normal.
Lan YT; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Yang SH
Hepatogastroenterology; 2012 May; 59(115):717-20. PubMed ID: 22024225
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
16. Serum carcinoembryonic antigen pre-operative level in colorectal cancer: revisiting risk stratification.
Iacuzzo C; Germani P; Troian M; Cipolat Mis T; Giudici F; Osenda E; Bortul M; de Manzini N
ANZ J Surg; 2021 Jun; 91(6):E367-E374. PubMed ID: 33870621
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
18. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
[TBL] [Abstract][Full Text] [Related]
19. What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.
Shinkins B; Nicholson BD; James T; Pathiraja I; Pugh S; Perera R; Primrose J; Mant D
Health Technol Assess; 2017 Apr; 21(22):1-60. PubMed ID: 28617240
[TBL] [Abstract][Full Text] [Related]
20. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
